Effect of dopamine agonist withdrawal after long-term therapy in prolactinomas. Studies with high-definition computerised tomography (Q72584542)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6146751%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

title

Effect of dopamine agonist withdrawal after long-term therapy in prolactinomas. Studies with high-definition computerised tomography (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6146751%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

1 reference

D G Johnston

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6146751%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

K Hall

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6146751%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

P Kendall-Taylor

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6146751%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

D Patrick

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6146751%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

M Watson

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6146751%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

D B Cook

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6146751%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

language of work or name

English

0 references

publication date

1 July 1984

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6146751%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6146751%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

volume

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6146751%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

issue

8396

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6146751%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

page(s)

187-192

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6146751%20AND%20SRC:MED&resulttype=core&format=json

Pergolide for the treatment of pituitary tumors secreting prolactin or growth hormone

27 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990480-X

7 January 2021

Recurrence of hyperprolactinemia after selective transsphenoidal adenomectomy in women with prolactinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990480-X

7 January 2021

Galactorrhoea: Successful Treatment with Reduction of Plasma Prolactin Levels by Brom-ergocryptine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990480-X

7 January 2021

Reduction in size of prolactin-secreting tumours in men treated with pergolide

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990480-X

7 January 2021

Hyperprolactinemia. Long-term effects of bromocriptine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990480-X

7 January 2021

Treatment of hyperprolactinaemia with pergolide mesylate: acute effects and preliminary evaluation of long-term treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990480-X

7 January 2021

Rapid Changes of Prolactinoma Volume after Withdrawal and Reinstitution of Bromocriptine*

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990480-X

7 January 2021

Drugs five years later. Bromocriptine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990480-X

7 January 2021

Hyperprolactinaemia in men-response to bromocriptine therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990480-X

7 January 2021

Metrizamide cisternography in pituitary and juxtapituitary lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990480-X

7 January 2021

Radioimmunoassay of Human Serum Thyrotrophin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990480-X

7 January 2021

Clomiphene citrate in men: increase of cortisol, luteinizing hormone, testosterone and steroid-binding globulins

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990480-X

7 January 2021

IMMUNOASSAY OF SERUM GROWTH HORMONE IN ACROMEGALIC PATIENTS.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990480-X

7 January 2021

Amenorrhoea, Galactorrhoea, and Primary Hypothyroidism with High Circulating Levels of Prolactin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990480-X

7 January 2021

Pituitary prolactinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990480-X

7 January 2021

Management of hyperprolactinaemic amenorrhoea

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990480-X

7 January 2021

Menstrual function and serum prolactin levels after long-term bromocriptine treatment of hyperprolactinaemic amenorrhoea

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990480-X

7 January 2021

Effects of bromocriptine on pituitary tumour size

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990480-X

7 January 2021

Conservative management of pituitary prolactinomas; evidence for bromocriptine-induced regression

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990480-X

7 January 2021

The Computed Tomographic Appearance of the Normal Pituitary Gland and Pituitary Microadenomas

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990480-X

7 January 2021

Human prolactin-producing adenomas and bromocriptine: a histological, immunocytochemical, ultrastructural, and morphometric study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990480-X

7 January 2021

Bromocriptine treatment reduces the cell size in human macroprolactinomas: a morphometric study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990480-X

7 January 2021

The Incidence of Complications During Pregnancy after Treatment of Hyperprolactinemia with Bromocriptine in Patients with Radiologically Evident Pituitary Tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990480-X

7 January 2021

Galactorrhea-amenorrhea syndrome: follow-up of forty-five patients after pituitary tumor removal.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990480-X

7 January 2021

10.1016/S0140-6736(84)90480-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6146751%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

1 reference